This is a phase III, prospective, multicenter, randomized, double-blind study evaluating the safety and efficacy of clarithromycin alone versus clarithromycin plus rifabutin versus rifabutin alone for the prevention of Mycobacterium avium Complex (MAC) bacteremia or disseminated MAC disease.
Showing the most recent 10 out of 869 publications